Mechanisms of COX-2 inhibitors a possible link to CV events?

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2005年 / 1056卷 / 1期

关键词：

Blood Flow; Medium Release; Organ Transplant; Prostacyclin; Vessel Diameter;

D O I：

10.2165/00128415-200510560-00009

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：5 / 5

相关论文

共 50 条

[21] No redemption for COX-2 inhibitors
Dorey, Emma
CHEMISTRY & INDUSTRY, 2006, (23) : 7 - 7
[22] Selective inhibitors of COX-2
不详
EXPERT OPINION ON THERAPEUTIC PATENTS, 1996, 6 (01) : 79 - 80
[23] Why do COX-2 inhibitors increase risk of cardiovascular events?
Frankish, H
LANCET, 2002, 359 (9315): : 1410 - 1410
[24] Selective COX-2 inhibitors
Parnham, MJ
DRUG NEWS & PERSPECTIVES, 1997, 10 (03) : 182 - 187
[25] COX-2 inhibitors in oncology
Haller, DG
SEMINARS IN ONCOLOGY, 2003, 30 (04) : 2 - 8
[26] Pharmacology of COX-2 inhibitors
Isakson, PC
COX-2: A NEW TARGET FOR CANCER PREVENTION AND TREATMENT, 2003, 37 : 25 - 51
[27] Selective COX-2 inhibitors
Pasero, C
McCaffery, M
AMERICAN JOURNAL OF NURSING, 2001, 101 (04) : 55 - 56
[28] COX-2 inhibitors: A review
Houston, AM
Teach, SJ
PEDIATRIC EMERGENCY CARE, 2004, 20 (06) : 396 - 399
[29] COX-2 inhibitors and the kidney
Appel, GB
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2001, 19 (06) : S37 - S40
[30] Novel COX-2 inhibitors
Lloyd, AW
DRUG DISCOVERY TODAY, 1998, 3 (08) : 386 - 386

← 1 2 3 4 5 →